Skip to main content

Selected Publications


Use of Non-invasive Testing to Stage Liver Fibrosis in Patients with HIV.

Journal Article Curr HIV/AIDS Rep · October 2016 Patients with HIV have a proclivity to develop liver fibrosis, especially when associated with other conditions such as HCV, HBV, and NAFLD. Identifying HIV-infected patients with significant fibrosis or cirrhosis plays an important role in clinical and th ... Full text Link to item Cite

MicroRNA-122 associates with serum apolipoprotein B but not liver fibrosis markers in CHC genotype 1 infection.

Journal Article J Med Virol · October 2015 miR-122 is the predominant liver miRNA that regulates hepatic lipid metabolism and inflammation. Hepatitis C virus (HCV) modulates host intracellular lipid metabolism. HCV stability and propagation also depend on an interaction between virus and miR-122. O ... Full text Link to item Cite

Individualized therapy for hepatitis C infection: focus on the interleukin-28B polymorphism in directing therapy.

Journal Article Mol Diagn Ther · February 2014 Hepatitis C virus—a major global cause of chronic hepatitis, cirrhosis, and hepatocellular carcinoma—affects millions of people worldwide. Pegylated interferon (Peg-IFN) and ribavirin (RBV) had been the standard treatment for a decade until availability of ... Full text Link to item Cite